Sono Tek (SOTK) Stock News

Sono-Tek (Nasdaq: SOTK) announced a technical collaboration with Diamond Quanta to integrate Sono-Tek’s precision ultrasonic coating systems into Diamond Quanta’s engineered diamond manufacturing workflows. The effort targets repeatable thin-film deposition, improved film uniformity, and progression toward OEM qualification and scalable manufacturing.

The collaboration emphasizes standardized process architecture to align engineered diamond-on-glass materials with semiconductor and electronics toolchains, supporting multilayer integration and manufacturability as Diamond Quanta advances toward qualification.

Sono-Tek (Nasdaq: SOTK) received a purchase order for $820,000 of ultrasonic coating equipment to be used in production of diagnostic medical devices. The order, placed through a subcontractor, scales an existing customer from earlier systems and is expected to ship in fiscal 2027.

The system deposits an electronically active layer, represents higher throughput and average selling price versus prior units, and comes from a different customer than earlier $5.0M and $2.8M medical device orders.

Sono-Tek (Nasdaq: SOTK) reported third-quarter and nine-month fiscal 2026 results for the period ended Nov. 30, 2025. Q3 net sales were $5.0M (seventh consecutive quarter >$5M) and nine-month sales were $15.3M (essentially flat YoY). Q3 gross margin expanded to 50% (QTD) and nine-month gross margin was 51%. Q3 net income rose 24% to $340k and nine-month net income rose 32% to $1.25M. Cash and marketable securities totaled $11.7M with no debt. Backlog reached a record $12.26M (up 16% YoY). The company reiterated FY2026 guidance, forecasting modest revenue growth.

Sono-Tek (NASDAQ: SOTK) reported second quarter and first half fiscal 2026 results for the period ended August 31, 2025, highlighting record first-half revenue of $10.30M and six consecutive quarters with >$5M quarterly sales. H1 net income rose 35% to $909K and Q2 net income increased 24% to $424K. Gross margin expanded to 51% (H1) and 50% (Q2), aided by favorable product mix and warranty expense. Cash, cash equivalents and marketable securities totaled $10.6M with no debt. Total equipment and service backlog was $11.21M, up 50% sequentially, driven by strong medical-market orders including ~$5M and ~$2.8M medical orders cited. Company updated FY26 guidance to modest revenue growth while noting tariff and clean-energy policy headwinds offset by medical demand.

Sono-Tek (Nasdaq: SOTK) received a purchase order valued at over $2.8 million from a major U.S. medical device manufacturer for multiple advanced ExactaCoat MD systems. The order comes from an existing customer that is ramping up production and adds higher-capability systems alongside equipment already in use. Deliveries are expected to begin in early calendar 2026 and complete within the first half of 2026. The company noted this award is from a different customer than a $5 million medical device order announced last month, which broadens its base of multi-million-dollar opportunities.

This reinforces Sono-Tek’s position in medical device coatings and supports its strategy of scaling production of higher-value systems.

Sono-Tek (NASDAQ: SOTK) will host a conference call on Tuesday, October 14, 2025 at 10:30 am ET to discuss fiscal second quarter and first half 2026 results for the period ended August 31, 2025. The company will issue its earnings press release before market open on October 14, 2025.

Dial-in: 1-844-481-2752 (U.S.) or 1-412-317-0668 (international). Webcast: accessible via the company website or the provided Chorus Call link. Replay available through October 21, 2025 at 1-877-344-7529 or 1-412-317-0088 (access code 6867548), and on the company website for one year.

Sono-Tek Corporation (Nasdaq: SOTK), a leading ultrasonic coating systems manufacturer, has secured a significant purchase order exceeding $5 million for medical device coating systems. The order comprises multiple advanced MediCoat systems designed for high-precision manufacturing.

The delivery of these systems is scheduled to begin in 2026 and will be completed over approximately 12 months. This major order represents growing adoption of Sono-Tek's advanced coating platforms in the medical device manufacturing sector and validates the company's strategy of focusing on complex, high-value production systems.

Sono-Tek (NASDAQ:SOTK), a leading ultrasonic coating systems manufacturer, reported strong Q1 FY2026 financial results. The company achieved its fifth consecutive quarter with revenue above $5 million, reporting net sales of $5.13 million, up 2% year-over-year.

Key highlights include a 103% increase in operating income to $483,000, gross margin expansion to 52% from 49%, and a 47% rise in net income to $485,000. The results were driven by a significant $2.95 million order in the advanced solar market and strong US/Canada sales, which increased 15% year-over-year.

While expecting continued growth in H1 FY2026, Sono-Tek maintains a cautious full-year outlook, projecting flat revenue growth due to uncertainty around clean energy incentives and tariff policies. The company holds a strong balance sheet with $10.9 million in cash and zero debt.

Sono-Tek Corporation (SOTK) has secured a significant $1.12 million order from a long-standing global medical diagnostics customer for a high-volume ultrasonic coating system. This order represents a major upgrade from previous mid-size systems ($110,000-$150,000 each) purchased by the same customer over their decade-long partnership. The new advanced automation platform will be installed at the customer's U.S. facility within a year, designed to enable scalable production of diagnostic consumables with reduced operator intervention. CEO Steve Harshbarger emphasized this order demonstrates their successful strategy of transitioning customers from R&D machines to complex large-scale production systems with higher Average Selling Prices.